Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2026-03-26 @ 9:08 PM
Study NCT ID:
NCT01543204
Status:
TERMINATED
Last Update Posted:
2017-12-29
First Post:
2012-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2012-01-17
First Submit QC Date:
None
Study First Post Date:
2012-03-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-18
Results First Submit QC Date:
None
Results First Post Date:
2016-06-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-05
Last Update Post Date:
2017-12-29
Last Update Post Date Type:
ACTUAL